Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Perspectives on Analytical Treatment Interruptions in People Living with HIV and Their Health Care Providers in the Landscape of HIV Cure-Focused Studies.

Lau JSY, Smith MZ, Allan B, Martinez C, Power J, Lewin SR, McMahon JH.

AIDS Res Hum Retroviruses. 2019 Dec 2. doi: 10.1089/AID.2019.0118. [Epub ahead of print]

PMID:
31608648
2.

Clinical trials of antiretroviral treatment interruption in HIV-infected individuals.

Lau JSY, Smith MZ, Lewin SR, McMahon JH.

AIDS. 2019 Apr 1;33(5):773-791. doi: 10.1097/QAD.0000000000002113.

PMID:
30883388
3.

Developing research priorities for Australia's response to infectious disease emergencies.

Lewin SR, Andrews RM, McVernon J, Milland J, Smith MZ, Sorrell TC; investigators of the Australian Partnership for Preparedness Research on Infectious Disease Emergencies
.

Commun Dis Intell Q Rep. 2017 Mar 31;41(1):E1-E3. No abstract available.

4.

Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy.

Khoury G, Anderson JL, Fromentin R, Hartogenesis W, Smith MZ, Bacchetti P, Hecht FM, Chomont N, Cameron PU, Deeks SG, Lewin SR.

AIDS. 2016 Jun 19;30(10):1511-20. doi: 10.1097/QAD.0000000000001029.

5.

Ureteral Compromise in Laparoscopic Versus Vaginal Uterosacral Ligament Suspension: A Retrospective Cohort.

Barbier HM, Smith MZ, Eto CU, Welgoss JA, Von Pechmann W, Horbach N, Gruber DD.

Female Pelvic Med Reconstr Surg. 2015 Nov-Dec;21(6):363-8. doi: 10.1097/SPV.0000000000000202.

PMID:
26506167
6.

Kinesin-1 interacts with Bucky ball to form germ cells and is required to pattern the zebrafish body axis.

Campbell PD, Heim AE, Smith MZ, Marlow FL.

Development. 2015 Sep 1;142(17):2996-3008. doi: 10.1242/dev.124586. Epub 2015 Aug 7.

7.

Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.

Elliott JH, Wightman F, Solomon A, Ghneim K, Ahlers J, Cameron MJ, Smith MZ, Spelman T, McMahon J, Velayudham P, Brown G, Roney J, Watson J, Prince MH, Hoy JF, Chomont N, Fromentin R, Procopio FA, Zeidan J, Palmer S, Odevall L, Johnstone RW, Martin BP, Sinclair E, Deeks SG, Hazuda DJ, Cameron PU, Sékaly RP, Lewin SR.

PLoS Pathog. 2014 Nov 13;10(10):e1004473. doi: 10.1371/journal.ppat.1004473. eCollection 2014 Oct.

8.

CD8+ T cells are activated in an antigen-independent manner in HIV-infected individuals.

Bastidas S, Graw F, Smith MZ, Kuster H, Günthard HF, Oxenius A.

J Immunol. 2014 Feb 15;192(4):1732-44. doi: 10.4049/jimmunol.1302027. Epub 2014 Jan 20.

9.

Impact of antigen specificity on CD4+ T cell activation in chronic HIV-1 infection.

Smith MZ, Bastidas S, Karrer U, Oxenius A.

BMC Infect Dis. 2013 Feb 25;13:100. doi: 10.1186/1471-2334-13-100.

10.

HIV reservoirs and strategies for eradication.

Smith MZ, Wightman F, Lewin SR.

Curr HIV/AIDS Rep. 2012 Mar;9(1):5-15. doi: 10.1007/s11904-011-0108-2. Review.

PMID:
22249405
11.

Safety, immunogenicity and efficacy of peptide-pulsed cellular immunotherapy in macaques.

De Rose R, Mason RD, Loh L, Peut V, Smith MZ, Fernandez CS, Alcantara S, Amarasena T, Reece J, Seddiki N, Kelleher AD, Zaunders J, Kent SJ.

J Med Primatol. 2008 Dec;37 Suppl 2:69-78. doi: 10.1111/j.1600-0684.2008.00329.x.

PMID:
19187433
12.

Interrupted vs. uninterrupted training on BMD during growth.

Goettsch BM, Smith MZ, O'Brien JA, Gomez GV, Jaque SV, Sumida KD.

Int J Sports Med. 2008 Dec;29(12):980-6. doi: 10.1055/s-2008-1038759. Epub 2008 Jul 9.

13.

Limited maintenance of vaccine-induced simian immunodeficiency virus-specific CD8 T-cell receptor clonotypes after virus challenge.

Smith MZ, Asher TE, Venturi V, Davenport MP, Douek DC, Price DA, Kent SJ.

J Virol. 2008 Aug;82(15):7357-68. doi: 10.1128/JVI.00607-08. Epub 2008 May 28.

14.

Control of viremia and prevention of AIDS following immunotherapy of SIV-infected macaques with peptide-pulsed blood.

De Rose R, Fernandez CS, Smith MZ, Batten CJ, Alcântara S, Peut V, Rollman E, Loh L, Mason RD, Wilson K, Law MG, Handley AJ, Kent SJ.

PLoS Pathog. 2008 May 2;4(5):e1000055. doi: 10.1371/journal.ppat.1000055.

15.

Resistance training and bone mineral density during growth.

Smith MZ, Goettsch BM, Van Ramshorst RD, O'Brien JA, Jaque SV, Sumida KD.

Int J Sports Med. 2008 Apr;29(4):316-21. Epub 2007 Sep 18.

16.

Killing kinetics of simian immunodeficiency virus-specific CD8+ T cells: implications for HIV vaccine strategies.

Rollman E, Smith MZ, Brooks AG, Purcell DF, Zuber B, Ramshaw IA, Kent SJ.

J Immunol. 2007 Oct 1;179(7):4571-9.

17.

Vaccine-induced T cells control reversion of AIDS virus immune escape mutants.

Fernandez CS, Smith MZ, Batten CJ, De Rose R, Reece JC, Rollman E, Venturi V, Davenport MP, Kent SJ.

J Virol. 2007 Apr;81(8):4137-44. Epub 2007 Jan 24.

18.

MHC class I allele frequencies in pigtail macaques of diverse origin.

Pratt BF, O'Connor DH, Lafont BA, Mankowski JL, Fernandez CS, Triastuti R, Brooks AG, Kent SJ, Smith MZ.

Immunogenetics. 2006 Dec;58(12):995-1001. Epub 2006 Nov 10.

PMID:
17096100
19.

Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques.

De Rose R, Batten CJ, Smith MZ, Fernandez CS, Peut V, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Venturi V, Davenport MP, Kent SJ.

J Virol. 2007 Jan;81(1):292-300. Epub 2006 Oct 18.

20.

Genetic influences on HIV infection: implications for vaccine development.

Smith MZ, Kent SJ.

Sex Health. 2005;2(2):53-62. Review.

PMID:
16335742
21.

The pigtail macaque MHC class I allele Mane-A*10 presents an immundominant SIV Gag epitope: identification, tetramer development and implications of immune escape and reversion.

Smith MZ, Fernandez CS, Chung A, Dale CJ, De Rose R, Lin J, Brooks AG, Krebs KC, Watkins DI, O'Connor DH, Davenport MP, Kent SJ.

J Med Primatol. 2005 Oct;34(5-6):282-93.

PMID:
16128923
22.

Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost.

Fernandez CS, Stratov I, De Rose R, Walsh K, Dale CJ, Smith MZ, Agy MB, Hu SL, Krebs K, Watkins DI, O'connor DH, Davenport MP, Kent SJ.

J Virol. 2005 May;79(9):5721-31.

23.

Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes.

Smith MZ, Dale CJ, De Rose R, Stratov I, Fernandez CS, Brooks AG, Weinfurter J, Krebs K, Riek C, Watkins DI, O'connor DH, Kent SJ.

J Virol. 2005 Jan;79(2):684-95.

24.

Constructional apraxia in Alzheimer's disease: association with occipital lobe pathology and accelerated cognitive decline.

Smith MZ, Esiri MM, Barnetson L, King E, Nagy Z.

Dement Geriatr Cogn Disord. 2001 Jul-Aug;12(4):281-8.

PMID:
11351139
25.

Hyperhomocysteinaemia in Alzheimer's disease and expression of cell cycle markers in the brain.

Nagy ZS, Smith MZ, Esiri MM, Barnetson L, Smith AD.

J Neurol Neurosurg Psychiatry. 2000 Oct;69(4):565-6. No abstract available.

26.

Coexisting pathologies in the brain: influence of vascular disease and Parkinson's disease on Alzheimer's pathology in the hippocampus.

Smith MZ, Nagy Z, Barnetson L, King EM, Esiri MM.

Acta Neuropathol. 2000 Jul;100(1):87-94.

PMID:
10912925
27.

Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease.

Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD.

Lancet. 1999 Sep 11;354(9182):919-20.

PMID:
10489957
28.

Cell cycle-related protein expression in vascular dementia and Alzheimer's disease.

Smith MZ, Nagy Z, Esiri MM.

Neurosci Lett. 1999 Aug 13;271(1):45-8.

PMID:
10471210
29.

Mutation at the putative GABA(A) ion-channel gate reveals changes in allosteric modulation.

Thompson SA, Smith MZ, Wingrove PB, Whiting PJ, Wafford KA.

Br J Pharmacol. 1999 Jul;127(6):1349-58.

Supplemental Content

Loading ...
Support Center